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Abstract
Background
The 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) together with parathyroid hormone (PTH) and
fibroblast growth factor 23 (FGF23) regulates calcium (Ca2+) and phosphate (Pi) homeosta-
sis, 1,25(OH)2D3 synthesis is mediated by hydroxylases of the cytochrome P450 (Cyp) fam-
ily. Vitamin D is first modified in the liver by the 25-hydroxylases CYP2R1 and CYP27A1
and further activated in the kidney by the 1α-hydroxylase CYP27B1, while the renal 24-
hydroxylase CYP24A1 catalyzes the first step of its inactivation. While the kidney is the
main organ responsible for circulating levels of active 1,25(OH)2D3, other organs also
express some of these enzymes. Their regulation, however, has been studied less.
Methods and results
Here we investigated the effect of several Pi-regulating factors including dietary Pi, PTH and
FGF23 on the expression of the vitamin D hydroxylases and the vitamin D receptor VDR in
renal and extrarenal tissues of mice. We found that with the exception of Cyp24a1, all the
other analyzed mRNAs show a wide tissue distribution. High dietary Pi mainly upregulated
the hepatic expression of Cyp27a1 and Cyp2r1 without changing plasma 1,25(OH)2D3.
FGF23 failed to regulate the expression of any of the studied hydroxylases at the used dos-
age and treatment length. As expected, renal mRNA expression of Cyp27b1 was reduced
and Cyp24a1 was increased in response to 1,25(OH)2D3 treatment. However, the 25-
hydroxylases were rather unaffected by 1,25(OH)2D3 treatment.
Conclusions
The analyzed vitamin D hydroxylases are regulated in a tissue and treatment-specific
manner.
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Introduction
The hormone 1,25-dihydroxyvitamin D3 (1,25(OH)2D3), together with fibroblast growth fac-
tor 23 (FGF23), parathyroid hormone (PTH) and dietary phosphate (Pi), plays a key role in
homeostasis of Pi. (for review see [1–3]) Additionally, these three hormones regulate each
other levels via positive and negative feedback loops, which makes difficult to discriminate
individual effects. In particular, 1,25(OH)2 vitamin D3 levels are blunted in response to high
dietary Pi [4], high FGF23 [5] and high 1,25(OH)2 vitamin D3 itself [6]. On the other hand,
while high dietary Pi and high FGF23 promote renal excretion of Pi, high 1,25(OH)2 vitamin
D3 promotes intestinal absorption of Pi. 1,25(OH)2D3 is also a regulator of calcium (Ca
2+)
homeostasis and in addition it may play an important role in degenerative diseases, cardiovas-
cular disease, and cancer [7]. The vitamin D3 precursor 7-dehydrocholesterol is converted to
previtamin D3 by the exposure of the epidermis and dermis to ultraviolet B radiation (290–
320 nm). In a temperature-depending reaction, this previtamin is isomerized to vitamin D3
before being transported to the blood circulation where it binds to the vitamin D-binding pro-
tein (DBP) [8]. Vitamin D2 and D3 as well as their metabolites 25-hydroxyvitamin D2, and D3
are also absorbed from the diet in the intestine [9]. The fat-soluble compounds are absorbed in
micelles by enterocytes and transported by chylomicrons into the lymphatic system and fur-
ther into the circulation [10].
To become the active form, vitamin D2 and D3 must undergo two modification steps cata-
lyzed by hydroxylases of the cytochrome P450 (Cyp) family. These enzymes possess specific
domains for the binding of a heme group and for the interaction with electron-transferring
proteins [11]. Both vitamin D2 and D3 are metabolized in a similar way; for simplification,
only the vitamin D3 modification reactions are summarized next. The first modification step
takes place in the liver where vitamin D3 is converted to 25-hydroxyvitamin D3 (25(OH)D3)
by hydroxylation at C-25. The hepatic 25-hydroxylases are the mitochondrial CYP27A1 and
the microsomal CYP2R1 [12]. CYP27A1 is expressed not only in the liver but is widely distrib-
uted and it hydroxylates vitamin D3 but not D2 [13]. Most probably CYP27A1 is not the major
25-hydroxylase since Cyp27a1 knockout mice have a two- to threefold increase in serum 25
(OH)D3 level, suggesting a compensatory role of CYP2R1 [14, 15]. Furthermore, deletion of
the Cyp27a1 gene does not result in rachitic phenotypes in mice [16]. On the other hand, the
microsomal CYP2R1 is mostly expressed in liver and testis and it is considered to play a major
role in 25-hydroxylation of vitamin D2 and D3, since mutations or depletion of Cyp2r1 lead to
reduced 25(OH)D3 levels [15, 17]. Nevertheless, additional enzymes with 25-hydroxylase
activities probably exist as Cyp2r1-/-/Cyp27a1-/- double knockout mice show similar 25(OH)D3
levels in plasma as Cyp2r1 knockout animals [15]. The second step of modification takes
place mainly in the proximal tubule of the kidney and it is mediated by the mitochondrial 1α-
hydroxylase encoded by the CYP27B1 gene, resulting in the production of the fully active 1,25
(OH)2D3 [13, 18]. In contrast to the 25-hydroxylation, the renal CYP27B1 is most probably
the only enzyme with 25(OH)D3 1α-hydroxylation activity since inactivating mutations in the
CYP27B1 gene abolish the production of 1,25(OH)2D3 and are the cause for vitamin D-depen-
dent rickets type I (also known as pseudovitamin D-deficiency rickets) [19]. Both 25(OH)D3
and 1,25(OH)2D3 are degraded by the mitochondrial CYP24A1, that catalyzes their 24- or
23-hydroxylation, finally resulting in either calcitroic acid or 1α,25-dihydroxyvitamin D-
26,23-lactone, respectively [12, 20]. Cyp24a1 knockout mice highlighted the important role of
this hydroxylase in the catabolism of vitamin D, as these mice showed severe hypercalcemia
with about 50% perinatal mortality [21]. Also in humans loss-of-function mutations in the
CYP24A1 are a main cause of the impaired vitamin D catabolism and lead to idiopathic infan-
tile hypercalcemia or hypercalciuric nephrocalcinosis and nephrolithiasis [22, 23].
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Both renal CYP27B1 and CYP24A1 are highly regulated. Thus, PTH stimulates the expres-
sion of CYP27B1 in the kidney, whereas FGF23, high Ca2+ or Pi levels and 1,25(OH)2D3 itself
downregulate it. In contrast, 1,25(OH)2D3 as well as FGF23 strongly induce the expression of
CYP24A1, whereas PTH reduces its expression by stimulating the degradation of its mRNA
[13]. Moreover, while PTH enhances the production of 1,25(OH)2D3, 1,25(OH)2D3 in turn
inhibits the production of PTH either directly at the transcription level of the PTH gene or
indirectly by increasing Ca2+ absorption in the intestine and stimulating the expression of
Ca2+ sensing receptors [24, 25]. Similarly, FGF23 suppresses the production of 1,25(OH)2D3,
but 1,25(OH)2D3stimulates the synthesis of FGF23 in bones [26].
In addition to the classical activation pathway described above (CYP27A1/CYP2R1 and
CYP27B1-mediated hydroxylations), vitamin D3 and D2 can be hydroxylated by the mitochon-
drial CYP11A1/P450scc [27]. The first and major product of this last reaction is 20-hydroxyvi-
tamin D3 (20(OH)D3), which can be further metabolized by CYP271 and CYP24A1. Many of
the products of this additional pathway where detected in human serum and where shown to
be biologically active; for review see [28].
The active 1,25(OH)2D3 exerts most of its biological functions via the binding to the vita-
min D receptor (VDR). The ligated receptor recognizes and binds to the vitamin D response
elements (VDRE) in target genes. This enables the formation of a heterodimer of the VDR and
the retinoid X receptor (RXR). The formed complex recruits multiple coregulators that possess
the ability to induce changes in gene expression of vitamin D target genes; for review see [3].
While renal expression and regulation of the vitamin D related hydroxylases are well docu-
mented, their extrarenal expression and local regulation are still poorly understood. In this
regard, the catabolic CYP24A1is found in vitamin D target tissues including bone and intes-
tine, while the activating 1α-hydroxylase CYP27B1 has been reported in skin, prostate,
parathyroid gland, pancreatic islets, testes, placenta and cells of the immune system like mac-
rophages and dendritic cells [13, 20]. This distribution of the 1α-hydroxylase in extrarenal tis-
sue, as well as the association of vitamin D with human granuloma-forming diseases such as
sarcoidosis or tuberculosis bring forward the argument of locally produced 1,25(OH)2D as a
paracrine/autocrine system [29, 30].
Here, were analyzed the pattern of expression of the above mentioned vitamin D related
hydroxylases (CYP27A1, CYP2R1, CYP27B1 and CYP24A1) as well as the VDR in murine
renal and extrarenal sites, and their regulation by factors that alter Pi metabolism, in order to
study whether or not regulation of 1,25(OH)2 vitamin D3 is achieved by similar mechanisms
regardless of the original signal.
Methods
Animal experiments
The study was approved by the local Veterinary Authority (Kantonales Veterina¨ramt Zu¨rich
Approval number: 05/2013). Male NMRI and C57BL/6 mice (8–10 weeks) were purchased
from Janvier Labs (France) and kept on standard diet (0.80% phosphate, 1.05% calcium, 1000
IU/kg vitamin D3, Promivi Kliba AG, CH) until the start of the experiments. Dietary phos-
phate: two randomized groups (each n = 6) of 10-week-old NMRI male mice were fed ad libi-
tum for seven days with either high (1.2%, HPD) or low (0.10%, LPD) phosphate diet (Promivi
Kliba AG, CH) with free access to water. On day eight all twelve animals were sacrificed and
samples were collected as described below. Values obtained with LPD-fed mice were consid-
ered as reference. FGF23 and vitamin D3 treatments: two randomized groups (each n = 6) of
12 week-old NMRI male mice were injected intraperitoneally either with FGF23 (R&D Sys-
tems, Bio-techne AG, UK) (40 μg/kg body weight diluted in 9% PBS/0.1% BSA, 125mM NaCl
Regulation of vitamin D3 metabolism
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and 10% ethanol) or with vehicle alone as control. The mice were injected intraperitoneally
once a day for two consecutive days and were then sacrificed on the third day; samples were
collected as described below. 1α,25(OH)2D3 (Sigma-Aldrich, Buchs, CH) was first dissolved in
100% ethanol to make 1 mM stocks (0.41664 μg/μl). Four randomized groups (each n = 6) of
10-week-old C57BL/6 male mice were injected intraperitoneally either with 1,25(OH)2D3
(4 μg/kg body weight diluted in 1.5% ethanol and 98.5% peanut oil) or with vehicle alone as
control. The mice were injected either once and sacrificed 14 hours later (short-term treat-
ment) or on day 0 and 2 and sacrificed on day 4 (long-term treatment).
For sample harvesting, each mouse was anaesthetized in an isoflurane chamber and kept
anaesthetized using a nose mask with flowing isoflurane/O2. The abdomen was opened and
the urinary bladder was emptied to collect spot urine. Urine was centrifuged at 10’000 rpm for
10 minutes and the supernatant was stored at -20 ˚C. A small piece of pancreas was cut and
snap-frozen in liquid nitrogen and stored at -80 ˚C. Blood was collected by cardiac puncture
of the left ventricle with heparin-prerinsed 1-ml syringes and 22G x 1 ¼ inch needles (B Braun
Medical AG, CH). Plasma was obtained by centrifuging the blood sample for 7 minutes at
7’000 rpm at 4 ˚C and aliquots were stored at -80 ˚C. Upon extraction of blood, each animal
was then perfused with 20 ml PBS directly by cardiac puncture of the left ventricle. The follow-
ing organs and tissues were then collected, frozen in liquid nitrogen, and stored at -80 ˚C for
further analysis: decapsulated kidney, liver, abdominal fat, brain, femur, small intestine and
colon. The intestinal tissue was washed with cold 0.9% sodium chloride, everted and scraped.
The mucosa was frozen in liquid nitrogen and stored at -80 ˚C for further analysis.
Phosphate, calcium and creatinine measurements
Phosphate in spot urine and plasma was measured by the Fiske and Subbarow method. Cal-
cium in spot urine and plasma was quantified using the QuantiChrom™ Calcium Assay Kit
(BioAssay Systems, USA), following the manufacturers’ protocol. Urinary creatinine determi-
nation was performed following Jaffe’s method.
PTH, FGF23 and 1,25(OH)2D3 measurements
PTH concentrations as well as human and mouse intact FGF23 levels in plasma were mea-
sured by ELISA (Immunotopics Inc., USA). Quantitative determination of 1,25(OH)2D3 in
plasma was performed by radioimmunoassay (Immunodiagnostic Systems, UK). This kit par-
tially cross-reacts with 1,25(OH)2D2. In all cases, measurements were done following the man-
ufacturers’ protocol.
Semi-quantitative real time RT-PCR
Kidney and intestinal mucosa were homogenized in RLT buffer (Qiagen Science, DE) supple-
mented with 1% β-mercaptoethanol. Bone marrow from femur samples was removed by flush-
ing bones with 0.9% sodium chloride. Bones were then smashed in a mortar before being
homogenized in QIAzol lysis buffer (Qiagen Science DE). Liver, abdominal fat tissue and
brain samples were also homogenized in QIAzol lysis buffer. RNA from homogenates was
extracted using the RNeasy Mini Kit (Qiagen Science, DE). cDNA was obtained by reverse
transcription of the isolated RNA using TaqMan1 Reverse Transcription kit (Thermo Fisher
Scientific, CH). RNA expression of several genes of interest was quantified by semi-quantita-
tive real time PCR (RT-qPCR) using gene-specific primers (25 μM) and probes (5 μM) (S1
Table) and the KAPA PROBE FAST qPCR Kit Master Mix (2x) Universal (Kapa Biosystems,
USA). Amplification of cDNA was performed in a 7500 Fast System cycler (Applied Biosys-
tems CH). Glyceraldehyde 3-phosphate dehydrogenase (Gapdh) was used as housekeeping
Regulation of vitamin D3 metabolism
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gene to normalize RNA expression of the target genes in all tissues except in bone for which
hypoxanthine phosphoribosyl-transferase (Hprt) was used, since the expression of Gapdh was
altered by some of the treatments. At a given threshold (Ct) the cycle number was measured
and normalized by the housekeeping gene as following: 2ðCtðcontrolÞ   CtðgeneÞÞ, resulting in the relative
gene expression.
Total renal protein extraction
Total protein extraction was achieved by homogenizing half a kidney in 300 μl RiPa buffer,
cotaining50 mM TrisHCl pH 7.4, 150 mM NaCl, 1% NP-40, 0.5% Na-Deoxycholate, 10 μl/ml
cOmplete™ EDTA-free Protease inhibitor cocktail (Roche Diagnostics AG, CH) and 2 mM
phenylmethylsulfonyl fluoride. Tissue samples were homogenized using MagNa Lyser Green
Beads and a Precellys1 24 Homogenizer. The samples were then centrifuged for 10 minutes at
top speed at 4 ˚C and the supernatants were collected. Protein concentration was determined
with a BioRad DC Protein Assay (BioRad Laboratories Inc., USA).
Western blot
Aliquots of homogenates containing 20 μg of total protein were mixed with 4x Laemmli sam-
ple buffer supplemented with 400 mM dithiothreitol (Thermo Scientific, CH), incubated for 2
minutes at 90 ˚C, separated into a 10% acrylamide SDS-PAGE and further transferred to a
nitrocellulose membrane (Immobilon1-P Transfer Membrane, Merck Millipore CH) by wet
transfer. The membranes were blocked for 30 minutes at room temperature (RT) with Tris
buffered saline supplemented with 0.1% Tween 20 (TBST) and 5% fat-free milk and further
incubated overnight at 4 ˚C with available primary antibodies against NaPi-IIa (dilution
1:3’000, University of Zurich, CH [31]), Klotho (dilution 1:1’000, TransGenic Inc., JP),
Cyp24a1 (dilution 1:1’000, Proteintech ™, UK), Vdr (dilution 1:500, Santa Cruz Biotechnology
Inc., USA) and β-actin (dilution 1:12’000, Sigma Aldrich, CH). After 3 washing steps with
TBST, the membranes were again blocked and incubated for 2 hours at RT with the appropri-
ate secondary (anti-mouse, -rabbit, -rat) antibody linked to horseradish peroxidase (HRP) (GE
Healthcare, UK; R&D Systems, USA). Upon 3 washing steps with TBST, membranes were
incubated with a HRP substrate (Merck Millipore CH) for 5 minutes. The chemiluminescent
signal was detected using the Luminescent Image Analyzer LAS-4000. Quantitiy One1 (Ver-
sion 4.6.1, BioRad) was used for the densitometric quantification and the expression of the
protein of interest was normalized to the expression of β-actin.
Statistical analysis
Data are presented as mean ± standard deviation and statistical analysis were performed with
GraphPad Prism Version 5.02, comparing two groups by unpaired Student’s t-Test. P values
0.05 were considered as statistically significant.
Results & discussion
High dietary Pi load increases the expression of 25-hydroxylases in the liver
Mice were kept for 5 days on either low (0.1%) or high (1.2%) Pi diets. To test whether the die-
tary protocols had produced the expected systemic adaptations, the concentrations of Pi and
Ca2+ in urine and plasma as well as the levels in plasma of several hormones were quantified
first. Mice fed high Pi diet (HPD) had significantly higher excretion of urinary Pi compared to
mice fed low Pi diet (LPD) (Fig 1A), while plasma Pi levels were similar in both groups (Fig
1B). In addition, HPD led to significantly lower urinary and serum Ca2+ levels (Fig 1C and 1D).
Regulation of vitamin D3 metabolism
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Fig 1. Effect of dietary Pi intake on mineral and hormonal levels. Urinary and plasma concentrations of Pi (A and
B) and Ca2+ (C and D) as well as plasma levels of PTH (E), intact FGF23 (F) and 1,25(OH)2D3 (G) in samples from
mice fed either high (1, 2%, HPD) or low (0.1%, LPD) Pi diet for seven days. Graphs show mean ± SD (n = 6/group).
Differences between both dietary groups were analyzed by unpaired student’s t-test with significant p values indicated
as:  p< 0.0001.
https://doi.org/10.1371/journal.pone.0195427.g001
Regulation of vitamin D3 metabolism
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These were the expected effects, as the kidney responds to high Pi intake with increased urinary
Pi excretion to maintain normal serum phosphate [32], and it has been reported that a diet
high in Pi decreases urinary and serum Ca2+ levels [33]. Mice adapted to a HPD had signifi-
cantly higher concentrations of intact PTH as well as intact FGF23 in plasma, compared to
mice fed LPD (Fig 1E and 1F), whereas plasma 1,25(OH)2D3 levels did not differ significantly
between the two groups (Fig 1G). FGF23 and PTH regulate Pi homeostasis by reducing the
capacity of the kidney to reabsorb Pi, thus inducing phosphaturia; reciprocally high plasma Pi
increases the levels of FGF23 and PTH [34, 35]. The low urinary excretion of Ca2+ observed in
the HPD group can further be explained by the binding of intestinal Ca2+ by intestinal Pi reduc-
ing its absorption and by the high PTH levels, as PTH enhances the reabsorption of Ca2+ in
the kidney [36]. Collectively, these data indicate that the dietary challenge had produced the
expected mineral and hormonal adaptations. The synthesis of 1,25(OH)2D3 is regulated by
PTH and FGF23, with PTH stimulating the synthesis and inhibiting the degradation of 1,25
(OH)2D3, whereas FGF23 downregulates the production and induces the catabolism of 1,25
(OH)2D3 in the kidney [24]. Therefore, the fact that similar levels of 1,25(OH)2D3 were detected
in the HPD and LPD groups may be explained based on the high PTH and FGF23 levels in the
HPD group, as both hormones might counterbalance their effects on the synthesis and catabo-
lism of 1,25(OH)2D3.
The 25-hydroxylase Cyp27a1 mRNA was detected in all analyzed organs (S2 Table), though
it was especially abundant in liver, colon, bone, and abdominal fat. Its expression was higher
in liver and abdominal fat of mice fed HPD compared with LPD, while the opposite pattern of
expression was detected in colon (Fig 2A). The other main 25-hydroxylase, namely Cyp2r1,
was also detected in all tested tissues (S2 Table), with liver and bone showing the highest levels.
Its hepatic abundance was also higher in mice fed HPD compared to mice fed LPD (Fig 2B).
This suggests that high dietary Pi intake may regulate the expression of the hepatic and fat
25-hydroxylases. Further studies are required to clarify whether this is a direct effect or
whether it requires PTH or FGF23, since both hormones were elevated. As low Ca2+ levels
were measured in plasma of mice fed HPD, Ca2+ could also lead to local stimulation of 25
(OH)D3 production in liver and adipose tissue. The fact that the expression pattern in colon is
the opposite to liver and fat indicates that the regulation of vitamin D metabolizing enzymes
might be cell and tissue specific. Although 1α-hydroxylase Cyp27b1 mRNA was detected in all
analyzed organs, its expression was especially abundant in kidney and bone whereas it was
very low in liver, small intestine and abdominal fat (S2 Table). Cyp27b1 abundance was higher
in the small intestine and colon of mice fed with HPD compared to those fed a LPD (Fig 2C).
It has been reported that in the absence of potent stimuli, the expression of the 24-hydroxylase
is low, even below the detectable level, in vitamin D target tissues [37]. Accordingly, and with
the only exception of kidney, the gene expression of Cyp24a1 was barely detectable (S2 Table).
Furthermore, dietary Pi seemed not to affect its expression in any of the analyzed organs (Fig
2D). Neither renal Cyp27b1 nor renal Cyp24a1 were regulated by dietary Pi, although dietary
effects were shown in C57BL/6 mice [38, 39]. Whether this lack of regulation is a strain-spe-
cific feature of NMRI mice needs further investigation. Vdr mRNA was detected in all organs
of interest except liver, where the expression was too low for consistent quantification, with
the higher levels detected in bone, colon small intestine and kidney (S2 Table). Vdr expression
was not regulated by dietary Pi in any of the analyzed tissues (Fig 2E). It is known that 1,25
(OH)2D3 enhances the expression of its own receptor [40]; thus the similar Vdr expression
detected in both dietary groups may reflect their similar 1,25(OH)2D3 plasma levels.
Mice fed HPD had reduced protein abundance of the renal sodium-dependent phosphate
cotransporter NaPi-IIa (Fig 3A). PTH as well as FGF23 (both increased in the HPD group)
lower serum Pi by decreasing the amount of NaPi-IIa in brush border membrane of renal
Regulation of vitamin D3 metabolism
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Fig 2. Dietary Pi intake changed extrarenal expression of 25- & 1α-hydroxylases. mRNA expression of Cyp27a1 (A), Cyp2r1 (B),
Cyp27b1 (C), Cyp24a1 (D) and Vdr (E) was measured in kidney (Ki), liver (Li), small intestine (Si), colon (Co), bone (Bo), abdominal
fat (Af) and brain (Br) samples of mice fed either high (HPD; 1.2% Pi) or low (LPD; 0.1% Pi) Pi diet for seven days. Expression of the
mRNA of interest was normalized to Gapdh (Hprt was used for normalization in bone). Graphs represent mean ± SD (n = 6/group) of
relative changes. Differences between both dietary groups were analyzed by unpaired student’s t-test with significant p values indicated
as:  p 0.05 and  p< 0.0001.
https://doi.org/10.1371/journal.pone.0195427.g002
Regulation of vitamin D3 metabolism
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Fig 3. Selective adaptation of renal protein expression to dietary Pi intake. Representative western blots of total
renal protein homogenates from mice fed high (HPD) or low (LPD) Pi diet using antibodies against NaPi-IIa (A), full
length Klotho (B), Cyp24a1 (C) and Vdr (D). The proteins of interest are shown in the top panels, whereas the
corresponding β-actin signal is shown in the bottom image. Densitometric quantifications were normalized to the
corresponding β-actin values. Bar graphs represent mean ± SD (n = 6/group) of the normalized values. Differences
between both dietary groups were analyzed by unpaired student’s t-test with significant p values indicated as:
 p 0.01 and  p< 0.0001.
https://doi.org/10.1371/journal.pone.0195427.g003
Regulation of vitamin D3 metabolism
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proximal tubule cells, thus suppressing renal Pi reabsorption [41–44]. Therefore, the low
NaPi-IIa protein expression reflects the expected adaptations to the high Pi load. High FGF23
also decreases the renal expression of its co-receptor Klotho [45]. Accordingly mice fed HPD
had lower renal Klotho protein expression compared to the LPD mice (Fig 3B). In agreement
with the mRNA data, the protein expression of Cyp24a1 and Vdr in the kidney did not differ
between the groups fed HPD or LPD (Fig 3C and 3D).
FGF23 treatment does not affect the expression of vitamin D-related
hydroxylases
The injected recombinant human FGF23 (rhFGF23) triggered the expected phosphaturic
effect, as mice injected with the hormone (once a day, for two consecutive days) exhibited a
threefold higher urinary Pi excretion (Fig 4A). Plasma Pi levels were unaffected (Fig 4B). In
this regard, it has been reported that single injections of FGF23 reduce plasma Pi [43]; however
this effect was shown to be transient and in agreement with our data normophosphatemia was
restored 24 hours after administration of FGF23. No significant changes in urinary Ca2+ excre-
tion were observed (Fig 4C), whereas injections with rhFGF23 led to an increase in plasma
Ca2+ levels compared to the control group (Fig 4D). In addition to its effect on Pi metabolism,
FGF23 also influences renal Ca2+ reabsorption by increasing the expression of Ca2+ channels
thereby enhancing Ca2+ transport in distal renal tubules [46]. These effects might explain the
elevated serum Ca2+ levels but not the unchanged urinary excretion of Ca2+ found in our ani-
mals. As expected, mice treated with rhFGF23 had lower serum PTH concentrations (Fig 4E),
as FGF23 downregulates the expression and secretion of PTH by the parathyroid [47]. Further-
more, injecting mice with rhFGF23 led to a significant decrease in plasma levels of endogenous
intact FGF23 (Fig 4F), suggesting that the exogenous hormone triggered a negative feedback
loop on the production of FGF23 by the mouse bone cells. rhFGF23 treatment did not affect
serum 1,25(OH)2D3 levels significantly (Fig 4G). Although strong reductions on 1,25(OH)2D3
concentration were found in mice 9 hours post FGF23 administration, this effect was also tran-
sient with values normalized after 24 hours [43]. rhFGF23 was detected in mice injected with
the recombinant protein even 24 hours after application (Fig 4H); its “detection” in control
animals probably reflects antibody’s cross-reaction with endogenous mouse FGF23 (Fig 4H).
Surprisingly, rhFGF23 did not affect the mRNA expression of Cyp27a1, Cyp2r1, Cyp27b1,
Cyp24a1 nor Vdr in none of the analyzed organs (Fig 5A–5E). In this regard, lower Cyp27b1
and higher Cyp24a1 were reported in kidneys of mice shortly (1–9 hours) after FGF23 treat-
ment, with values normalizing thereafter [43].
Mice injected with rhFGF23 had reduced renal NaPi-IIa protein expression (Fig 6A). This
observation, together with hyperphosphaturia and reduced serum PTH levels indicates that
the treatment induced the expected consequences on Pi homeostasis. However, and against
expectations [45], the protein expression of Klotho (Fig 6B) was not affected by the rhFGF23
treatment. This absence of regulation may be eventually explained by the reduced levels of
endogenous FGF23, probably counterbalancing the presence of rhFGF23, or by the additional
regulation of klotho by other factors not controlled in this experiment. In agreement with the
RNA data, the protein abundance of Cyp24a1 was similar in rhFGF23 and vehicle-injected
animals (Fig 6C). Further experiments should be performed, testing whether different dosages
or treatment lengths might lead to the expected effects in the renal hydroxylases. Interestingly,
mice injected with rhFGF23 have lower Vdr protein expression in the kidney, compared to
control animals (Fig 6D), suggesting that FGF23 may regulate the expression of Vdr in a vita-
min D3 -independent way. Alternatively, a putative low 1,25(OH)2D3 at early time points may
affect hydroxylases and Vdr with different time-courses.
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Fig 4. Effect of FGF23 administration on mineral and hormonal levels. Urinary and plasma concentrations of Pi (A
and B) and Ca2+ (C and D) as well as plasma levels of PTH (E), endogenous FGF23 (F), 1,25(OH)2D (G) and
recombinant human FGF23 (H) were measured in samples from mice injected with recombinant human FGF23
(rhFGF23) once a day for two consecutive days (black bars) and the respective vehicle treated controls (white bars).
Graphs show mean ± SD (n = 5-6/group) and data was analyzed by unpaired student’s t-test with significant p values
indicated as:  p 0.05 and  p 0.01.
https://doi.org/10.1371/journal.pone.0195427.g004
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Fig 5. FGF23 did not alter the RNA expression of vitamin D-related hydroxylases and the Vdr. Gene expression of Cyp27a1 (A),
Cyp2r1 (B), Cyp27b1 (C), Cyp24a1 (D) and Vdr (E) was measured in kidney (Ki), liver (Li), small intestine (Si), colon (Co), bone (Bo),
abdominal fat (Af) and brain (Br) samples of mice injected with recombinant human FGF23 (rhFGF23) once a day for two consecutive
days (black bars) and the respective vehicle treated controls (white bars). Expression of the genes of interest was normalized to Gapdh
(Hprt was used for normalization in bone). Graphs represent mean ± SD (n = 5-6/group) of relative changes, and data was analyzed by
unpaired student’s t-test.
https://doi.org/10.1371/journal.pone.0195427.g005
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Fig 6. FGF23 treatment led to changes in renal NaPi-IIa and Vdr protein expression. Representative western blots
of total renal protein homogenates from mice injected with either vehicle (Ctrl) or recombinant human FGF23
(rhFGF23) once a day for two consecutive days using antibodies against NaPi-IIa (A), full length Klotho (B), Cyp24a1
(C) and Vdr (D). The proteins of interest are shown in the top panels, whereas the corresponding β-actin signal is
shown in the bottom image. Densitometric quantification was normalized to the corresponding β-actin values. Bar
graphs represent mean ± SD (n = 5-6/group) of the normalized values and data was analyzed by unpaired student’s t-
test with significant p values indicated as:  p 0.05.
https://doi.org/10.1371/journal.pone.0195427.g006
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1,25(OH)2D3 treatment regulates mainly the expression of its hydroxylases
in the kidney
1,25(OH)2D3 itself is an effective regulator of its own metabolism, suppressing CYP27B1 in
kidney and inducing CYP24A1 in vitamin D3 target tissues [48, 49]. Therefore, the systemic
response to 1,25(OH)2D3 administration was analyzed in short-term and long-term experi-
ments. For both protocols, urinary Pi excretion did not differ between treated and the corre-
sponding control groups (Fig 7A), while plasma Pi levels were increased in the short-term
but no in long term experiments (Fig 7B). The latter results were expected, since vitamin D
enhances intestinal Pi absorption, thereby resulting in a transient increase in plasma Pi,
while also FGF23 is increased by 1,25(OH)2D3 counteracting an elevation of plasma Pi. 1,25
(OH)2D3 further regulates the transcellular absorption of Ca
2+ in epithelial cells of the intestine
[50]. Although only a trend for higher urinary excretion was observed for the long-term treat-
ment (Fig 7C), serum Ca2+ levels were elevated in both groups injected with 1,25(OH)2D3 (Fig
7D). 1,25(OH)2D3 inhibits the synthesis of PTH [24] whereas it increases the production of
FGF23 [26], with the stimulated FGF23 potentially suppressing renal Pi reabsorption. Indeed,
PTH levels were reduced whereas FGF23 concentration was increased upon short-term and
long-term vitamin D administration (Fig 7E). Collectively, the above data suggest that 1,25
(OH)2D3 administration induced the expected systemic responses, except for the absence of a
hyperphosphaturic response especially in the long term protocol, where in addition to high
FGF23 animals had normalized their plasma Pi values. Mice subjected to the long-term treat-
ment had significantly lower serum 1,25(OH)2D3 levels compared to the control mice (Fig
7G), suggesting that after a certain treatment length the exogenous administration led either to
a decrease of the endogenous production or to an increase in degradation; alternatively, the
lower plasma levels may reflect increased binding of the hormone to the Vdr and subsequent
internalization into target cells. Similar changes in plasma 1,25(OH)2D3 levels have been
reported in 1,25(OH)2D3 treated mice [51].
The expression of Cyp27a1 mRNA (detected in all analyzed organs) was exclusively regulated
in kidney where both short and long-term treatment with 1,25(OH)2D3 led to a downregulation
of the hydroxylase (Fig 8A). These changes suggest a potential feedback mechanism that sup-
presses the renal production of 25(OH)D3 in response to high 1,25(OH)2D3. Nevertheless, this
assumption requires further investigations, since the detailed mechanisms of the regulation of
Cyp27a1 are unknown. Surprisingly, 1,25(OH)2D3 did not alter the hepatic expression of
Cyp27a1 (Fig 8A). In all tested organs, Cyp2r1 expression remained unaffected by the two differ-
ent 1,25(OH)2D3 applications (Fig 8B). In response to 1,25(OH)2D3 administration renal
Cyp27b1 was reduced whereas renal Cyp24a1 expression was increased in both the short and
long-term protocols (Fig 8C and 8D). In the long-term application these changes are consistent
with the lower 1,25(OH)2D3 levels in plasma. Interestingly, both 1,25(OH)2D3 treatments failed
to affect extrarenal Cyp27b1 expression. As for the dietary and FGF23 studies, the expression of
Cyp24a1 was mainly detected in kidney under basal conditions and only at very low levels in the
other organs analyzed. Treatment with 1,25(OH)2D3 increased Cyp24a1 in the kidney as well as
in small intestine and transiently in colon (Fig 8D). As for the dietary and FGF23 treatments,
Vdr expression was detected in all tissues except in liver (S2 Table). Although the expression of
the vitamin D receptor is expected to be upregulated by 1,25(OH)2D3 [40], the effects seem to
be tissue and time dependent. Thus, renal mRNA expression of Vdr was increased for both pro-
tocols, whereas only transient changes were detected in bone (Fig 8E).
Surprisingly, hyperphosphatemia and/or high FGF23 associated with 1,25(OH)2D3 admin-
istration did not correlate with reduced NaPi-IIa expression in total renal homogenates
(Fig 9A). Thus, further experiments testing brush border membrane preparation should be
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Fig 7. Effect of 1,25(OH)2D3 administration on mineral and hormonal levels. Urinary and plasma concentrations
of Pi (A and B) and Ca2+ (C and D) as well as plasma levels of PTH (E), FGF23 (F) and 1,25(OH)2D3 (G) were
measured in samples from mice injected with 1,25(OH)2D3 either once within 14 hours (14h) or twice within 96 hours
(96h) and their respective controls. Graphs show mean ± SD (n = 6/group) and data was analyzed by unpaired
student’s t-test with significant p values indicated as:  p 0.05,  p 0.01 and  p< 0.0001.
https://doi.org/10.1371/journal.pone.0195427.g007
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Fig 8. 1,25(OH)2D3 treatment mainly changed renal mRNA expression. mRNA expression of Cyp27a1 (A), Cyp2r1 (B), Cyp27b1 (C),
Cyp24a1 (D) and Vdr (E) were measured in kidney (Ki), liver (Li), small intestine (Si), colon (Co), bone (Bo), abdominal fat (Af) and brain
(Br) samples of mice injected with 1,25(OH)2D3 either once within 14 hours (14h, grey bars) or twice within 96 hours (96h, black bars)
and their corresponding controls (white and striped bars, respectively). Expression of the mRNAs of interest was normalized to Gapdh
(Hprt was used for normalization in bone). Graphs represent mean ± SD (n = 6/group) of relative changes (given as percentage and
normalized to controls at 14 and 96 hrs, respectively) and data was analyzed by unpaired student’s t-test with significant p values indicated
as:  p 0.05,  p 0.01 and  p< 0.0001.
https://doi.org/10.1371/journal.pone.0195427.g008
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Fig 9. 1,25(OH)2D3 administration regulated the protein abundance of NaPi-IIa, klotho and Vdr. Representative
western blots of total renal protein homogenates from mice injected with 1,25(OH)2D3 either once within 14 hours
(14h) or twice within 96 hours (96h) and the corresponding controls using antibodies against NaPi-IIa (A), full length
Klotho (B), Cyp24a1 (C) and Vdr (D). The proteins of interest are shown in the top panels, whereas the corresponding
β-actin signal is shown in the bottom image. Densitometric quantification was normalized to the corresponding β-
actin values. Bar graphs represent mean ± SD (n = 6/group) of the normalized values and data was analyzed by
unpaired student’s t-test with significant p values indicated as:  p 0.05,  p 0.01 and  p< 0.0001.
https://doi.org/10.1371/journal.pone.0195427.g009
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performed to rule out that this apparent lack of regulation is due to membrane retrieval with-
out complete NaPi-IIa degradation. 1,25(OH)2D3 has been shown to upregulate klotho mRNA
in mouse kidney cell lines [52], however, in our in vivo experiments short term 1,25(OH)2D3
administration did not induce any changes in the protein expression whereas a reduction in
renal klotho protein was observed in the long-term experiment (Fig 9B). This reduction was
most probably provoked by the high FGF23 levels. The strong stimulation of the catabolizing
enzyme Cyp24a1 on mRNA level by 1,25(OH)2D3 treatment did not result in higher protein
abundance (Fig 9C). Further analysis of renal Cyp27b1 protein expression is clearly needed
but hampered by the lack of specific antibodies. As it was already seen on mRNA level,
renal protein expression of Vdr was increased upon short- or long-term treatment with 1,25
(OH)2D3 (Fig 9D).
In summary, we have shown that: a) all analyzed genes involved in vitamin D metabolism
show a wide tissue distribution, with the exception of the Cyp24a1, b) the regulation of their
gene expression is tissue and treatment specific, c) chronic changes in dietary Pi mostly regu-
late the expression of 25-hydroxylases in liver, colon and abdominal fat, but these changes are
not paralleled by altered levels of 1,25(OH)2D3 in plasma, d) short administration of FGF23
triggering major hormonal and mineral changes has no significant effects on vitamin D-regu-
lating enzymes, suggesting different time courses for both actions, and e) 1,25(OH)2D3 treat-
ment leads to major changes in renal hydroxylases.
Supporting information
S1 Table. Sequences of primers and probes used to quantify the mRNA expression of
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